PURE Bioscience receives FDA approval for use of SDC antimicrobial as poultry processing aid to reduce pathogens
PURE Bioscience, Inc., creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that the FDA has completed its review of the safety and efficacy of the proposed use of silver dihydrogen citrate (SDC) as a raw poultry processing aid and declared PURE Bioscience’s food contact notification (FCN) to be effective as of December 18, 2015.
Dramatic SDC test results show consistent reductions in pathogen levels -- including the potential to reduce Salmonella on raw poultry to below detection levels. A breakthrough technology, SDC is a non-toxic food safety solution (safe for both people and the environment) – delivering superior efficacy when compared with other processing aids used in the market today.
USDA Approval Process Proceeding
The final step in the regulatory approval process for commercialization of SDC-based PURE Control® in poultry processing is to obtain USDA approval. With receipt of the FDA’s approval, PURE is engaged in the review and approval process with the Food Safety and Inspection Service of the USDA. This process will involve plant trials under the authorization of the USDA. The Company is working with partner processors and laboratories, has developed protocols, and is designing the equipment necessary for the trials.